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Abstract.  The precise localization  of dystrophin  in the 
skeletal muscle cell should contribute  to a better un- 
derstanding  of the yet unclear  functional  role of this 
protein,  both in normal and in Duchenne  muscular 
dystrophy.  Immunocytochemical  studies did not give 
conclusive results on the localization  of dystrophin 
with respect to the sarcolemma and to the cytoskeletal 
components.  To improve the reliability of the electron 
microscopic immunocytochemical  localization  of dys- 
trophin,  a  mAb against the COOH-terminus  of the 
molecule has been used in association with the frac- 
ture-label technique,  which,  causing  a partition  of the 
membrane  in protoplasmic  and exoplasmic halves,  al- 
lows a more precise dystrophin localization.  The  re- 
suits obtained indicate that dystrophin  is associated 
with the protoplasmic  half of the plasmalemma,  and 
the observation that  it does not randomly  follow the 
partition  of the membrane  is consistent with a  stable 
association with the cytoskeleton. 
UCHErqrqE and Becker muscular dystrophy (DMD and 
BMD) 1 are progressive  muscular  disorders  which 
result from defects in a 2,000-kb X-gene at position 
Xp21. By reverse genetics it was possible, at first, to isolate 
the gene, and then to employ the DNA to identify the gene 
product (16, 10). Immunological studies with antisera raised 
in sheep led to the discovery of a new protein,  the dystro- 
phin,  present in small quantities in normal skeletal muscle 
(0.002%), but absent or altered in DMD, mdx mouse, and 
BMD (12). 
Dystrophin has a 427-kD molecular mass and,  as it has 
been predicted from the amino acid sequence, it shares some 
structural features with the cytoskeletal proteins spectrin and 
alpha-actinin  (14).  According  to these  structural  homolo- 
gies, four domains have been identified:  the NH2 terminal, 
with  sequence homologies to the actin-binding  domain of 
alpha-actinin; a long spectrin-like repeat domain, referred to 
as rod-like;  a cysteine-rich domain with a weak homology 
to  alpha-actinin;  and  finally  a  COOH-terminal  domain 
which shows similarity to an autosomal analogue of dystro- 
phin (18). 
Cell fractionation  studies suggested that dystrophin may 
be associated with triads and, in particular,  with their T-tu- 
bule component (11), but subsequent immunocytochemical 
1. Abbreviations used in this  paper: BMD, Becker muscular dystrophy; c.g., 
colloidal gold conjugated antibody; CPD-FL, critical point drying fracture 
label; DMD, Dueherme muscular dystrophy; E, exoplasmic; P, protoplas- 
mic; TSFL, thin section fracture label. 
studies revealed that dystrophin is localized at the periphery 
of the muscle fiber close to the plasma membrane, with no 
correlation with the T-tubule system (6). A periodical distri- 
bution  of dystrophin,  was reported  by using  anti-rod-like 
fraction  antibodies  (6,  22),  while a  uniform  labeling  was 
found by using anti-NH2-terminal  antibodies (4). 
An electron microscopic study, carried  out on cryosec- 
tions,  using  a  colloidal  gold  (c.g.)  conjugated  antibody 
against the rod-like domain of dystrophin, suggested that this 
portion of the protein is normally arranged close to the cyto- 
plasmic face of the plasma membrane and that the dystrophin 
molecules form an interconnecting  network (6). 
It is thought that the NH:- and COOH-terminal domains 
may mediate  the binding  between the cytoskeleton and  a 
membrane glycoprotein complex, composed of four or more 
subunits (3, 8, 9), some of which may be integral glycopro- 
teins: in fact a reduction of membrane glycoprotein binding 
lectins was demonstrated in DMD muscle (9). 
A considerable interest is now focused on the structure and 
function of the COOH-terminal domain: it has been shown 
by using a mAb against a peptide in the COOH-terminal end 
of the  dystrophin  molecule,  that  the  COOH  terminus  is 
preserved in BMD and absent in DMD patients (1), support- 
ing the hypothesis that in BMD the reading frame of the gene 
is maintained  (17). 
To investigate the function of dystrophin, efforts have been 
made to precisely localize the molecule with respect to the 
cytoplasmic membrane.  Morphological investigations,  based 
on the use of isolated sarcolemmal vesicles, showed at the 
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COOH-terminal domains localized at the cytoplasmic face 
of the plasma membrane (23). On the other hand, it has been 
hypothesized that the COOH-terminal  fraction is localized 
in the plasma membrane, closer to the outer than to the inner 
membrane half, by means of calculations on the statistical 
distribution  of the  label  on muscle cryosections,  using  a 
polyclonal antibody (7).  A  model of the dystrophin-asso- 
ciated glycoproteins,  based on immunochemical  methods, 
has been recently proposed in which the dystrophin is local- 
ized in the subsarcolemmal region where it could mediate 
the binding between cytoskeletal F-actin and membrane gly- 
coproteins (at the COOH- and NH2-terminal ends,  respec- 
tively) (8). 
The aim of this study is to localize the COOH-terminal 
fraction,  at the  electron  microscopic level,  on  the  whole 
muscle cells. For this purpose we used a mAb (raised against 
a synthetic polypeptide corresponding to the last 17 amino 
acids  of the  COOH-terminal  end  of dystrophin)  for pre- 
embedding  labeling  of cryosections  and  frozen  fractured 
samples (fracture-label).  The latter technique allows one to 
split the membranes along a middle plane, obtaining two dis- 
tinct membrane halves (19) to which the observed label can 
be definitely ascribed. 
Materials and Methods 
Normal human quadriceps femoralis fragments, obtained from biopsies of 
nondystrophic patients,  and rat soleus samples were fixed in 0.001% glutar- 
aldehyde- 2 % paraformaldehyde  in 0.1 M sodium phosphate buffer (PB) for 
1 h  at 4~ 
Cryoultramicrotomy 
The samples were cryoprotected  in 2.3 M sucrose for90 min, frozen in liq- 
uid nitrogen (LN2), and sectioned at -90~  in a Reichert Ultracut micro- 
tome equipped with FC4 cryosectioning unit. After immunolabeling (see 
paragraph), the sections were impregnated with Epon and stained with ura- 
nyl acetate and lead citrate. 
Fracture-label 
The samples were cryoprotected  with 30% glycerol in 0.1 M PB for 20 rain 
at room temperature. One group of them underwent critical point drying 
fracture label (CPD-FL) (19): for this purpose they were mounted on gold 
supports, frozen in freon 22-LN2,  fractured in a Balzers BAF 400 D ap- 
paratus, and thawed  in 30% glycerol  in PB.  After immunolaheling (see 
paragraph), they were dehydrated with ethanol, dried at the critical point 
in a Balzers  CPD 030 apparatus,  replicated  with 2 nm platinum at 45* 
and 20 nm carbon at 90* in Balzers  BAF 400 D, and digested  in sodium 
hypochlorite. 
A second group underwent thin section fracture label (TS-FL) (19). After 
freezing in freon 22-LN2,  they  were  fractured in LN2 with a  precooled 
metal pestle; thawing, labeling, and dehydration were the same as for CPD- 
FL.  Then the  samples were  embedded in Epon and  sectioned with a 
Reichert Ultracut ultramicrotome. The sections were stained with uranyl 
acetate and lead citrate. After the labeling, some debris of fractured tissue 
was used for the following technique. 
Sectioned Replica 
Debris of fracture-labeled tissue was embedded in 4% gelatin in PB, cross- 
linked with 2.5% glutaraldehy~le for 1 h, cryoprotected  in 30% glycerol- 
0.1 M PB, frozen in freon 22-LN2,  fractured, and shadowed with 2 nm Pt 
at 45  ~ in Balzers BAF 400 D (carbon coating was deliberately omitted). 
These samples were then processed with the sectioned replica technique 
(20):  thawing  in 30%  glycerol-0.1  M  PB,  dehydration in ethanol, and 
embedding in Epon. To obtain broad replicated areas immersed in the thick- 
ness of the sections,  the plane of cutting was parallel to the replicated 
surface. 
Immunolabeling 
All samples were washed in PBS, pH 7.2,  containing 0.5% BSA (Sigma 
Chemical Co., St. Louis,  MO) and 0.15% glycine,  then in PBS-BSA, and 
incubated with 5% normal goat serum (Sigma Chemical Co.) in PBS-BSA 
for 30 min at room temperature.  The samples were then incubated for 1 h 
with undiluted primary antidystrophin mAb Dys 2  (raised in the mouse 
against a synthetic polypeptide corresponding to the COOH-terminal 17 
amino acids of dystrophin (Novocastra,  Newcastie-upon-Tyne,  UK) at room 
temperature, washed in PBS-BSA, and incubated with the secondary anti- 
body-colloidal  gold complex (goat-antimouse  conjugated with 10 nm c.g.) 
(Janssen, Belgium), 10% in PBS-BSA, and finally washed with PBS-BSA. 
Controls were incubated in PBS-BSA instead of the first antibody. In these 
conditions the label was completely absent (data not shown). The Dys 2 an- 
tibody, tested in immunoblot analysis, recognizes a single band of ~400 
Mr, as reported by Clerk et al. (5) (data not shown). 
After labeling the samples were fixed in 2.5% glutaraldehyde in 0.1 M 
PB and processed for the different techniques mentioned above. On some 
cryosections  the reaction was amplified with IntenSE EM Silver Enhance- 
ment Kit (Amersham International, Amersham, UK) for 7 min. 
Results 
Cryoultramicrotomy 
No background label is present in cryosections, neither in 
the outer space, nor in the myofibrils and in the sarcoplasmic 
reticulum  membranes.  The labeling  is present exclusively 
along the sarcolemma, while the endomysium is free of gran- 
ules (Fig.  1 a).  In those areas where the endomysium has 
been detached, the sarcolemma is much more intensely la- 
beled (Fig.  1 c) than in the areas where the endomisium is 
still present (Fig.  1 b). In this case, a mechanical damage of 
the membrane probably occurs during cutting, causing situa- 
tion similar to TS-FL described below. However, the mem- 
brane damage cannot be controlled on cryosections; more- 
over, the localization of the c.g. granules with respect to the 
membrane cannot be finely determined because of the larger 
size of the Ab-gold complex in comparison with the mem- 
brane thickness. 
Fracture-label 
For defining the fractured surfaces,  the nomenclature pro- 
posed by Branton et al.  (2) has been followed. 
In thin-sectioned-fractured-labeled samples the labeling is 
found only along the profiles of fractured sarcolemma, while 
contiguous membranes of endothelial cells are completely 
negative (Fig. 2).  In the muscle cells the label is localized 
in close association with the profile of the fractured mem- 
brane,  specifically on the protoplasmic  (P) half (2), while 
the exoplasmic (E) half as well as the myofilaments and the 
collagen fibers (Fig. 3, a and b) are free ofc.g, granules. The 
Figure L  Human muscle, cryosectioning. In two adjacent muscle cells (a, silver enhancement), the e.g. granules are detectable only along 
the sarcolemma (arrows) of the cell in which the endomysium (En) has been detached; no background is visible. The intensity of labeling 
is greatly dependent on the presence of the endomysium: where it is present only a few granules (arrows) are visible (b), while numerous 
granules are present all along the sarcolemma after the endomysium detachment (c).  M,  myofilaments. 
Squarzoni et al. Localization of Dystrophin by Fracture-label  1403 Figure 2. Rat muscle, TS-FL. The c.g. granules are visible only along the fractured sarcolemma (arrows), while the endothelial cell mem- 
brane (EC), the basal lamina (BL)), the nuclear envelope (NE), and the nucleoplasm (N) show no label along the fracture profile. 
membrane often appears  rearranged  (Fig.  3,  c  and d) as 
usual in frozen-fractured and thawed samples (19).  In the 
samples processed with the CPD-FL method, the fractured 
areas are not only seen as profiles, but also as "en face" sur- 
faces; the c.g. granules are adhering to the replica and are 
seen superimposed on it. More precisely, the c.g. granules 
were localized on the tissue and covered with the platinum 
layer (replica).  The digestion in  sodium hypochlorite re- 
moves the tissue, but the c.g. granules remain attached under 
the replica, making them appear superimposed on the plati- 
num layer. The general aspect of this kind of replica is quite 
different from routinely freeze-fractured and replicated sam- 
pies, due to the fact that in the CPD-FL method the samples 
are replicated after thawing, labeling, and chemical dehydra- 
tion-CPD steps. The cell morphology, however, is quite well 
preserved: myofilaments  are easily recognized, as well as the 
membrane P halves at the myofiber border (Fig. 4, a and c). 
The E half  of  the membrane is difficult  to identify; therefore, 
the absence of  labeling on it relies on the observation of  anal- 
ogous fields in the TS-FL method. 
The labeling pattern in these samples (Fig. 4, a and b) is 
comparable with that of cryosections: when the membranes 
are cross fractured together with the endomysium, the c.g. 
granules are localized at the periphery of the myofibers, in 
the plasma membrane zone. When the fracture has gone in 
the membrane plane, splitting away the external half and the 
endomysium, the P half is intensely labeled (Fig. 4, c and 
d).  The  cytoplasm, collagen,  and endomysium show  no 
background labeling. 
Sectioned Replica 
The sectioned replica technique is a useful method for com- 
paring, in the same picture, the morphology obtained by two 
different techniques: freeze-fracture replication and section- 
ing, i.e., in our experiment, CPD-FL and TS-FL. For this 
purpose we replicated some labeled tissue fragments, ob- 
tained from the TS-FL method before the dehydration. Also 
the embedding of samples processed for the CPD-FL, in 
place of the tissue digestion step,  should give analogous 
results but with a worse replica quality. The labeling shown 
on these samples is comparable (for the sectioned portion) 
with that of the TS-FL, while on the replicated portion only 
few e.g. granules are visible, due to the limited extension, 
in the section thickness, of the replicated rim. The e.g. gran- 
ules are present along the profile of the P membrane half 
either on the sectioned portion or on the replicated portion 
(Fig. 5 a); and, if the second fracture has gone in the same 
plane  of the  first  one,  some  granules  appear  shadowed 
(Fig. 5 b). 
Discussion 
The Dys 2 mAb, which in Western blot identifies a single 
band of ~400 Mr (5),  in the experimental conditions for 
immunocytochemistry  presents a high specificity since only 
the sarcolemma is labeled, while the membranes of  the other 
cells and the cytoplasmic structures are completely negative. 
The cytochemical reaction produces, on cryosections, a 
The Journal  of Cell Biology,  Volume 118, 1992  1404 Figure 3. Rat muscle, TS-FL. In a, the c.g. granules (arrows) are concentrated along the protoplasmic membrane half profile (P) of the 
lower fiber; fragments of the exoplasmic membrane half (E) adhering to the endomysium (En) are unlabeled. The membrane of the upper 
fiber (arrowheads) has not been fractured and is, therefore, unlabeled. In b (incomplete fracture), both the unlabeled exoplasmic (E) and 
the labeled protoplasmic (P) profiles of the sarcolemma are visible. Details of the P half are visible in c and d. In all figures, membrane 
discontinuities and blebs are visible, which derive from postfracture rearrangement of the half membrane layers. Figure 4. Human muscle, CPD-FL. (a) Low magnification of a cross fractured muscle fiber. M, myofilaments; C, collagen, b shows detail 
of the squared area in a; c.g. granules are visible along the membrane profile (arrows), (c) Low magnification of the ~en face" fractured 
membrane; the protoplasmic membrane half (P) has been partially exposed by the fracture which then has gone through the muscle cell; 
M, myofilaments, d shows detail of the squared area in c; groups of c.g. granules are present on the protoplasmic layer; the labeling is 
quite intense, no background is present inside the cytoplasm. 
Figure 5.  Rat muscle, sectioned replica. The label is present only on the surfaces exposed by the first fracture (analogous to the TS-FL 
samples); the replicated areas have been exposed by the second fracture. Where the two fracture planes converge, some e.g. granules are 
visible superimposed to the replica (a and b, arrowheads). On the sectioned areas the profiles of the P membrane half are labeled as in 
TS-FL (a, arrows). Mi, mitochondrion; M, myofilaments; G, gelatin. In b a small area of labeled P membrane half (shown at lower magni- 
fication in the insert) has been intersected by the second fracture plane, exposing some e.g. granules to the platinum shadowing (arrows); 
Mi, mitochondrion. 
The Journal of Cell Biology,  Volume 118, 1992  1406 Squarzoni et al. Localization of Dystrophin by Fracture,4abel  1407 constant labeling along the sarcolemma. It is noteworthy that 
where the endomysium has been detached from the plas- 
malemma, the labeling on the latter is markedly increased, 
suggesting that specific antigens could have been exposed al- 
lowing more c.g. granules to be bound and all of them to be 
viewed, even those which are localized on the membrane 
surface in the section thickness. The probable mechanism of 
the splitting of the endomisium, which could involve the 
membrane, could be the mechanical stress during sectioning 
(13),  analogous  to  the  fracturing  process  in  the  freeze- 
fracture technique. The precise localization of the label with 
respect to the membrane is not possible on cryosections, un- 
less using theoretical calculations, by which Cullen et al. (7) 
has recently proposed an intramembrane localization of dys- 
trophin. In fact, the possibility that the c.g. granules may be 
localized in the range of 40 am from the epitope (6) makes 
the cryosections, whose thickness is rarely smaller than 100 
nm, of little reliability for determining the localization of 
dystrophin over a structure (the membrane) whose thickness 
is ,o8 nm. 
For localizing the dystrophin COOH-terminal fraction we 
used  preembedding  labeling  and  the  fracture-label  tech- 
nique. This method enabled us to carry out the reaction on 
two distinguishable membrane halves, as well as to minimize 
the manipulation of the sample, because the most denaturing 
steps are carried out only after the immunolabeling. More- 
over,  it is possible, by the sectioned replica technique, to 
localize the c.g. granules, present in the section thickness, 
with respect to the replicated structures at the sample frac- 
ture surface, and to directly compare the two different FL 
methods. The main drawbacks of the sectioned replica are, 
however, the limited extension of the replica (proportional to 
the section thinness) and the scarce probability of finding 
c.g. granules at the replica surface. 
The label in TS-FL samples is present only on the profiles 
of the P membrane half. The resolution of the cell substruc- 
tures is increased in comparison with cryosections, but the 
number of visible c.g. granules is smaller due to the section 
thinness. The E membrane half is distinctly visible and ap- 
pears devoid of c.g.; this suggests that dystrophin does not 
remain attached to the external layer of the plasmalemma 
during fracture and agrees with the reported internal local- 
ization of dystrophin in isolated membrane vesicles (23). 
The localization of c.g. on the P membrane half is confirmed 
by the CPD-FL technique, which allows us to look at the 
fractured membrane from above:  small groups of c.g. gran- 
ules appear on the membrane layer still attached to the pro- 
toplasm; in cross fractured membranes the localization of 
c.g.  granules  resembles  that of cryosections and TS-FL. 
Since the identification of E membrane halves by CPD-FL 
is very difficult in muscle samples, the absence of labeling 
on them can be determined only on TS-FL samples. 
The presence of the c.g. marker on the P membrane half 
should not be misinterpreted as a localization on a true pro- 
toplasmic fracture face which is normally isolated from the 
aqueous environment. In frozen-fractured and thawed tissues 
the observation of labeled hydrophilic groups on an appar- 
ently hydrophobic membrane surface is likely to be allowed 
by the local rearrangement of the membranes after the frac- 
ture. During this process, in fact, it is possible that mem- 
brane proteins facing the protoplasm are shifted towards the 
external environment, where they can be labeled as well as 
the proteins which were immersed in the inner lipid layer, 
exposed by the fracture.  This process  could also  involve 
membrane-associated proteins,  such as dystrophin, which 
although it is not a membrane protein, is known to be tightly 
attached to the membrane protoplasmic surface (9, 23). 
We found, in fact, a particularly evident increase in label- 
ing on cryosections, where the sarcolemma has been me- 
chanically damaged following the  detachment of the  en- 
domysium; moreover, in TS-FL we could directly find traces 
of the  rearrangement as  blebs  and  discontinuities of the 
membrane. 
We determined the  localization of the  COOH-terminal 
fraction of dystrophin by labeling after thawing the fractured 
sample, i.e., after the rearrangement has happened.  Since 
we split up the membrane before labeling and find c.g. gran- 
ules only on the P membrane half, our data suggest that the 
COOH-terminal  domain  is  associated  with  the  internal 
membrane layer, probably with the COOH hydrophilic end 
originally on the protoplasmic surface, and that it is not pos- 
sible to distinguish between protoplasmic fracture face and 
protoplasmic surface localization by the FL technique. Ac- 
cording to previous hypothesis on membrane protein parti- 
tion (21), the observation that dystrophin does not randomly 
follow the partition of the membrane lipid layers should sug- 
gest that it is maintained attached to the protoplasm by stable 
interactions, probably with the cytoskeleton, and that the 
reported binding to membrane glycoproteins (which should 
have  a  transmembrane  domain)  (8)  does  not  affect this 
preferential partition. 
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